Ocular Therapeutix (OCUL) Tops Q3 EPS by 11c

Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.39), $0.11 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $477 thousand versus the consensus estimate of $470 thousand.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
• A strong earnings season looks likely to help restore market confidence - UBS
• Blue Foundry Bancorp (BLFY) Tops Q1 EPS by 9c